Topic List : Immunology

  • Immune-cell 'brake' on inflammation

    Deficits in a recently discovered immune cell’s function may trigger a rare age-related auto-inflammatory disease — and perhaps far more common ones, too.

  • Cancer immunotherapy center launched

    Crystal Mackall will lead a cancer immunotherapy center at Stanford that is being launched with an initial $10 million grant from the Parker Foundation.

  • $10 million grant funds infection-focused center

    The new center will explore intracellular and intercellular processes by which salmonella bacteria, responsible for more than 100 million symptomatic infections annually, infect immune cells.

  • Rheumatoid arthritis drug trial success

    A new drug appears to help people who suffer from rheumatoid arthritis, but eventually stop benefitting from the use of the current top treatment: injectable, bioengineered proteins that interfere with the action of a powerful inflammatory substance.

  • Resurrecting a drug

    Stanford scientists found that a discarded drug helps human cells in a lab dish fight off two different viruses. Based on what they learned about how the drug works, it might also help fight the viruses that cause Ebola, dengue and Zika, among others.

  • New center to study human microbiome

    The center will accelerate research bent on learning more about the internal microbial ecosystems with which we co-exist, and on applying this knowledge to enhance people’s health.

  • Too much glucose in, heart disease out

    Excessive glucose uptake by inflammatory immune cells called macrophages, which reside in arterial plaques, may be behind coronary artery disease.

  • Bacterial diversity in dolphins

    The findings could help scientists detect potential health problems facing marine mammals due to climate change, as well as answer a mystery about how dolphins digest whole fish.

  • Compound kills drug-resistant malaria pathogen

    Teasing apart subtle differences between a protein-shredding structure found in malaria parasites and in human cells enabled researchers to design a compound targeting the parasite without harming human tissue.

  • Heritable gut-bug loss from low-fiber diet

    When mice with gut bacteria from a human were put on a low-fiber diet, the diversity of their intestinal inhabitants plummeted. Four generations on a low-fiber diet caused irreversible losses.